APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anticoagulant Reversal Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anticoagulant Reversal Drug Industry Growth and Trends Forecast to 2032

20 December 202595 pages

Choose your research edition.

Industry ResearchAnticoagulant Reversal Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Anticoagulant Reversal Drug Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Anticoagulant Reversal Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anticoagulant Reversal Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Anticoagulant Reversal Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Anticoagulant Reversal Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anticoagulant Reversal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anticoagulant Reversal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anticoagulant Reversal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anticoagulant Reversal Drug include Pfizer, Fresenius Kabi, Portola Pharmaceuticals, Perosphere Pharmaceuticals, Octapharma, CSL, Boehringer Ingelheim, Bausch Health Companies and Amneal Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anticoagulant Reversal Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anticoagulant Reversal Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anticoagulant Reversal Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anticoagulant Reversal Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anticoagulant Reversal Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anticoagulant Reversal Drug Market by Company

Pfizer

Fresenius Kabi

Portola Pharmaceuticals

Perosphere Pharmaceuticals

Octapharma

CSL

Boehringer Ingelheim

Bausch Health Companies

Amneal Pharmaceuticals

Anticoagulant Reversal Drug Segment by Type

Protamine

Vitamin K

Prothrombin Complex Concentrates

Tranexamic Acid

Anticoagulant Reversal Drug Segment by Application

Hospital Pharmacies

Retail Pharmacies

Others

Anticoagulant Reversal Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulant Reversal Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anticoagulant Reversal Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulant Reversal Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anticoagulant Reversal Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anticoagulant Reversal Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Protamine Table 2. Major Company of Vitamin K Table 3. Major Company of Prothrombin Complex Concentrates Table 4. Major Company of Tranexamic Acid Table 5. Global Anticoagulant Reversal Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Anticoagulant Reversal Drug Sales by Type (2021-2026) & (k units) Table 7. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Anticoagulant Reversal Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Anticoagulant Reversal Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Anticoagulant Reversal Drug Price by Type (2021-2026) & (US$/unit) Table 11. Global Anticoagulant Reversal Drug Sales by Type (2027-2032) & (k units) Table 12. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Anticoagulant Reversal Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Anticoagulant Reversal Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Anticoagulant Reversal Drug Price by Type (2027-2032) & (US$/unit) Table 16. North America Anticoagulant Reversal Drug Sales by Type (2021-2026) & (k units) Table 17. North America Anticoagulant Reversal Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Anticoagulant Reversal Drug Sales by Type (2021-2026) & (k units) Table 19. Europe Anticoagulant Reversal Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Anticoagulant Reversal Drug Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Anticoagulant Reversal Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Anticoagulant Reversal Drug Sales by Type (2021-2026) & (k units) Table 23. Latin America Anticoagulant Reversal Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Anticoagulant Reversal Drug Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Anticoagulant Reversal Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Anticoagulant Reversal Drug Industry Trends Table 27. Anticoagulant Reversal Drug Industry Drivers Table 28. Anticoagulant Reversal Drug Industry Opportunities and Challenges Table 29. Anticoagulant Reversal Drug Industry Restraints Table 30. Global Anticoagulant Reversal Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Anticoagulant Reversal Drug Revenue Market Share by Company (2021-2026) Table 32. Global Anticoagulant Reversal Drug Sales by Company (2021-2026) & (k units) Table 33. Global Anticoagulant Reversal Drug Sales Share by Company (2021-2026) Table 34. Global Anticoagulant Reversal Drug Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Anticoagulant Reversal Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Anticoagulant Reversal Drug Major Company Production Sites and Headquarters Table 37. Global Anticoagulant Reversal Drug Company, Product Type & Application Table 38. Global Anticoagulant Reversal Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Anticoagulant Reversal Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Anticoagulant Reversal Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Anticoagulant Reversal Drug Sales by Region (2021-2026) & (k units) Table 43. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Anticoagulant Reversal Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Anticoagulant Reversal Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Anticoagulant Reversal Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Anticoagulant Reversal Drug Sales by Region (2027-2032) & (k units) Table 48. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Anticoagulant Reversal Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Anticoagulant Reversal Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Anticoagulant Reversal Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Anticoagulant Reversal Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Anticoagulant Reversal Drug Sales by Application (2021-2026) & (k units) Table 54. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Anticoagulant Reversal Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Anticoagulant Reversal Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Anticoagulant Reversal Drug Price by Application (2021-2026) & (US$/unit) Table 58. Global Anticoagulant Reversal Drug Sales by Application (2027-2032) & (k units) Table 59. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Anticoagulant Reversal Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Anticoagulant Reversal Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Anticoagulant Reversal Drug Price by Application (2027-2032) & (US$/unit) Table 63. North America Anticoagulant Reversal Drug Sales by Application (2021-2026) & (k units) Table 64. North America Anticoagulant Reversal Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Anticoagulant Reversal Drug Sales by Application (2021-2026) & (k units) Table 66. Europe Anticoagulant Reversal Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Anticoagulant Reversal Drug Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Anticoagulant Reversal Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Anticoagulant Reversal Drug Sales by Application (2021-2026) & (k units) Table 70. Latin America Anticoagulant Reversal Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Anticoagulant Reversal Drug Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Anticoagulant Reversal Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pfizer Anticoagulant Reversal Drug Product Portfolio Table 77. Pfizer Recent Development Table 78. Fresenius Kabi Company Information Table 79. Fresenius Kabi Business Overview Table 80. Fresenius Kabi Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Fresenius Kabi Anticoagulant Reversal Drug Product Portfolio Table 82. Fresenius Kabi Recent Development Table 83. Portola Pharmaceuticals Company Information Table 84. Portola Pharmaceuticals Business Overview Table 85. Portola Pharmaceuticals Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Portola Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio Table 87. Portola Pharmaceuticals Recent Development Table 88. Perosphere Pharmaceuticals Company Information Table 89. Perosphere Pharmaceuticals Business Overview Table 90. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio Table 92. Perosphere Pharmaceuticals Recent Development Table 93. Octapharma Company Information Table 94. Octapharma Business Overview Table 95. Octapharma Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Octapharma Anticoagulant Reversal Drug Product Portfolio Table 97. Octapharma Recent Development Table 98. CSL Company Information Table 99. CSL Business Overview Table 100. CSL Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. CSL Anticoagulant Reversal Drug Product Portfolio Table 102. CSL Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Anticoagulant Reversal Drug Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Bausch Health Companies Company Information Table 109. Bausch Health Companies Business Overview Table 110. Bausch Health Companies Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Bausch Health Companies Anticoagulant Reversal Drug Product Portfolio Table 112. Bausch Health Companies Recent Development Table 113. Amneal Pharmaceuticals Company Information Table 114. Amneal Pharmaceuticals Business Overview Table 115. Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Amneal Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio Table 117. Amneal Pharmaceuticals Recent Development Table 118. North America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. North America Anticoagulant Reversal Drug Sales by Country (2021-2026) & (k units) Table 120. North America Anticoagulant Reversal Drug Sales Market Share by Country (2021-2026) Table 121. North America Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032) & (k units) Table 122. North America Anticoagulant Reversal Drug Sales Market Share Forecast by Country (2027-2032) Table 123. North America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Anticoagulant Reversal Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Anticoagulant Reversal Drug Market Share by Country (2021-2026) Table 126. North America Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Anticoagulant Reversal Drug Market Share Forecast by Country (2027-2032) Table 128. Europe Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Europe Anticoagulant Reversal Drug Sales by Country (2021-2026) & (k units) Table 130. Europe Anticoagulant Reversal Drug Sales Market Share by Country (2021-2026) Table 131. Europe Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032) & (k units) Table 132. Europe Anticoagulant Reversal Drug Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Anticoagulant Reversal Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Anticoagulant Reversal Drug Market Share by Country (2021-2026) Table 136. Europe Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Anticoagulant Reversal Drug Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Anticoagulant Reversal Drug Sales by Country (2021-2026) & (k units) Table 140. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032) & (k units) Table 142. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Anticoagulant Reversal Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Anticoagulant Reversal Drug Market Share by Country (2021-2026) Table 146. Asia-Pacific Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Anticoagulant Reversal Drug Market Share Forecast by Country (2027-2032) Table 148. Latin America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Latin America Anticoagulant Reversal Drug Sales by Country (2021-2026) & (k units) Table 150. Latin America Anticoagulant Reversal Drug Sales Market Share by Country (2021-2026) Table 151. Latin America Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032) & (k units) Table 152. Latin America Anticoagulant Reversal Drug Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Anticoagulant Reversal Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Anticoagulant Reversal Drug Market Share by Country (2021-2026) Table 156. Latin America Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Anticoagulant Reversal Drug Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Anticoagulant Reversal Drug Sales by Country (2021-2026) & (k units) Table 160. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032) & (k units) Table 162. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Anticoagulant Reversal Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Anticoagulant Reversal Drug Market Share by Country (2021-2026) Table 166. Middle East and Africa Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Anticoagulant Reversal Drug Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Anticoagulant Reversal Drug Distributors List Table 171. Anticoagulant Reversal Drug Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Anticoagulant Reversal Drug Image Figure 2. Global Anticoagulant Reversal Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anticoagulant Reversal Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anticoagulant Reversal Drug Sales (2021-2032) & (k units) Figure 5. Protamine Image Figure 6. Global Protamine Sales YoY Growth (2021-2032) & (k units) Figure 7. Vitamin K Image Figure 8. Global Vitamin K Sales YoY Growth (2021-2032) & (k units) Figure 9. Prothrombin Complex Concentrates Image Figure 10. Global Prothrombin Complex Concentrates Sales YoY Growth (2021-2032) & (k units) Figure 11. Tranexamic Acid Image Figure 12. Global Tranexamic Acid Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Anticoagulant Reversal Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Anticoagulant Reversal Drug Market Share by Type 2025 VS 2032 Figure 15. North America Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Anticoagulant Reversal Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Anticoagulant Reversal Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anticoagulant Reversal Drug Market Share by Application 2025 VS 2032 Figure 35. North America Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Anticoagulant Reversal Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Anticoagulant Reversal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anticoagulant Reversal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anticoagulant Reversal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anticoagulant Reversal Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Anticoagulant Reversal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anticoagulant Reversal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anticoagulant Reversal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anticoagulant Reversal Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Anticoagulant Reversal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anticoagulant Reversal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anticoagulant Reversal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anticoagulant Reversal Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Anticoagulant Reversal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anticoagulant Reversal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anticoagulant Reversal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anticoagulant Reversal Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Anticoagulant Reversal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anticoagulant Reversal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anticoagulant Reversal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anticoagulant Reversal Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anticoagulant Reversal Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Protamine
  • Vitamin K
  • Prothrombin Complex Concentrates
  • Tranexamic Acid
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Portola Pharmaceuticals
  • Perosphere Pharmaceuticals
  • Octapharma
  • CSL
  • Boehringer Ingelheim
  • Bausch Health Companies
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anticoagulant Reversal Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anticoagulant Reversal Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anticoagulant Reversal Drug Market by Type
  6. 1.3.1 Protamine
  7. 1.3.2 Vitamin K
  8. 1.3.3 Prothrombin Complex Concentrates
  9. 1.3.4 Tranexamic Acid
  10. 1.4 Global Anticoagulant Reversal Drug Market Size by Type
  11. 1.4.1 Global Anticoagulant Reversal Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Anticoagulant Reversal Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Anticoagulant Reversal Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Anticoagulant Reversal Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Anticoagulant Reversal Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Anticoagulant Reversal Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Anticoagulant Reversal Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Anticoagulant Reversal Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anticoagulant Reversal Drug Industry Trends
  2. 2.2 Anticoagulant Reversal Drug Industry Drivers
  3. 2.3 Anticoagulant Reversal Drug Industry Opportunities and Challenges
  4. 2.4 Anticoagulant Reversal Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anticoagulant Reversal Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Anticoagulant Reversal Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Anticoagulant Reversal Drug Price (2021-2026)
  4. 3.4 Global Anticoagulant Reversal Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anticoagulant Reversal Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Anticoagulant Reversal Drug Company, Product Type & Application
  7. 3.7 Global Anticoagulant Reversal Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anticoagulant Reversal Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anticoagulant Reversal Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anticoagulant Reversal Drug Tier 1, Tier 2, and Tier 3
4 Anticoagulant Reversal Drug Regional Status and Outlook
  1. 4.1 Global Anticoagulant Reversal Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anticoagulant Reversal Drug Historic Market Size by Region
  3. 4.2.1 Global Anticoagulant Reversal Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anticoagulant Reversal Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anticoagulant Reversal Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anticoagulant Reversal Drug Forecasted Market Size by Region
  7. 4.3.1 Global Anticoagulant Reversal Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anticoagulant Reversal Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anticoagulant Reversal Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anticoagulant Reversal Drug by Application
  1. 5.1 Anticoagulant Reversal Drug Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Anticoagulant Reversal Drug Market Size by Application
  6. 5.2.1 Global Anticoagulant Reversal Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anticoagulant Reversal Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anticoagulant Reversal Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anticoagulant Reversal Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anticoagulant Reversal Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anticoagulant Reversal Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anticoagulant Reversal Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anticoagulant Reversal Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Anticoagulant Reversal Drug Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Fresenius Kabi
  8. 6.2.1 Fresenius Kabi Company Information
  9. 6.2.2 Fresenius Kabi Business Overview
  10. 6.2.3 Fresenius Kabi Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fresenius Kabi Anticoagulant Reversal Drug Product Portfolio
  12. 6.2.5 Fresenius Kabi Recent Developments
  13. 6.3 Portola Pharmaceuticals
  14. 6.3.1 Portola Pharmaceuticals Company Information
  15. 6.3.2 Portola Pharmaceuticals Business Overview
  16. 6.3.3 Portola Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Portola Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio
  18. 6.3.5 Portola Pharmaceuticals Recent Developments
  19. 6.4 Perosphere Pharmaceuticals
  20. 6.4.1 Perosphere Pharmaceuticals Company Information
  21. 6.4.2 Perosphere Pharmaceuticals Business Overview
  22. 6.4.3 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio
  24. 6.4.5 Perosphere Pharmaceuticals Recent Developments
  25. 6.5 Octapharma
  26. 6.5.1 Octapharma Company Information
  27. 6.5.2 Octapharma Business Overview
  28. 6.5.3 Octapharma Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Octapharma Anticoagulant Reversal Drug Product Portfolio
  30. 6.5.5 Octapharma Recent Developments
  31. 6.6 CSL
  32. 6.6.1 CSL Company Information
  33. 6.6.2 CSL Business Overview
  34. 6.6.3 CSL Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSL Anticoagulant Reversal Drug Product Portfolio
  36. 6.6.5 CSL Recent Developments
  37. 6.7 Boehringer Ingelheim
  38. 6.7.1 Boehringer Ingelheim Company Information
  39. 6.7.2 Boehringer Ingelheim Business Overview
  40. 6.7.3 Boehringer Ingelheim Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Boehringer Ingelheim Anticoagulant Reversal Drug Product Portfolio
  42. 6.7.5 Boehringer Ingelheim Recent Developments
  43. 6.8 Bausch Health Companies
  44. 6.8.1 Bausch Health Companies Company Information
  45. 6.8.2 Bausch Health Companies Business Overview
  46. 6.8.3 Bausch Health Companies Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bausch Health Companies Anticoagulant Reversal Drug Product Portfolio
  48. 6.8.5 Bausch Health Companies Recent Developments
  49. 6.9 Amneal Pharmaceuticals
  50. 6.9.1 Amneal Pharmaceuticals Company Information
  51. 6.9.2 Amneal Pharmaceuticals Business Overview
  52. 6.9.3 Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Amneal Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio
  54. 6.9.5 Amneal Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Anticoagulant Reversal Drug Sales by Country
  2. 7.1.1 North America Anticoagulant Reversal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anticoagulant Reversal Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anticoagulant Reversal Drug Market Size by Country
  6. 7.2.1 North America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anticoagulant Reversal Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anticoagulant Reversal Drug Sales by Country
  2. 8.1.1 Europe Anticoagulant Reversal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anticoagulant Reversal Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anticoagulant Reversal Drug Market Size by Country
  6. 8.2.1 Europe Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anticoagulant Reversal Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anticoagulant Reversal Drug Sales by Country
  2. 9.1.1 Asia-Pacific Anticoagulant Reversal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anticoagulant Reversal Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anticoagulant Reversal Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anticoagulant Reversal Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anticoagulant Reversal Drug Sales by Country
  2. 10.1.1 South America Anticoagulant Reversal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anticoagulant Reversal Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anticoagulant Reversal Drug Market Size by Country
  6. 10.2.1 South America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anticoagulant Reversal Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anticoagulant Reversal Drug Sales by Country
  2. 11.1.1 Middle East and Africa Anticoagulant Reversal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anticoagulant Reversal Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anticoagulant Reversal Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anticoagulant Reversal Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anticoagulant Reversal Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anticoagulant Reversal Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anticoagulant Reversal Drug Value Chain Analysis
  2. 12.1.1 Anticoagulant Reversal Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anticoagulant Reversal Drug Production Mode & Process
  7. 12.2 Anticoagulant Reversal Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anticoagulant Reversal Drug Distributors
  10. 12.2.3 Anticoagulant Reversal Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst